Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Exponential rise in COVID-19 hospitalization risk with age due to waning T cell immunity

Exponential rise in COVID-19 hospitalization risk with age due to waning T cell immunity

No safe level of caffeine consumption for pregnant women

No safe level of caffeine consumption for pregnant women

Blood cancer patients are more vulnerable to the effects of COVID-19, study finds

Blood cancer patients are more vulnerable to the effects of COVID-19, study finds

Using engineered off-the-shelf therapeutic T cells to fight cancer

Using engineered off-the-shelf therapeutic T cells to fight cancer

Researchers develop vaccine for human herpesvirus 6B

Researchers develop vaccine for human herpesvirus 6B

Study identifies key gene as future therapeutic target for aggressive endometrial cancer

Study identifies key gene as future therapeutic target for aggressive endometrial cancer

Potential inhibitors of SARS-CoV-2 identified

Potential inhibitors of SARS-CoV-2 identified

Study uses a statistical approach to reveal patterns of cancer incidence

Study uses a statistical approach to reveal patterns of cancer incidence

Scientists identify genetic link to predict treatment response in patients with aggressive blood cancer

Scientists identify genetic link to predict treatment response in patients with aggressive blood cancer

Researchers identify new mechanism that causes leukemia

Researchers identify new mechanism that causes leukemia

Neil Bell appointed as Chief Development Officer of Avacta Life Sciences

Neil Bell appointed as Chief Development Officer of Avacta Life Sciences

Combination regimen improves overall survival in certain patients with AML

Combination regimen improves overall survival in certain patients with AML

Screening for malnutrition may help identify ACS patients at high risk of adverse outcomes

Screening for malnutrition may help identify ACS patients at high risk of adverse outcomes

COVID-19 patient with repeatedly undetectable SARS-CoV-2 antibodies

COVID-19 patient with repeatedly undetectable SARS-CoV-2 antibodies

Powerful treatment for IPF stops dangerous scar formation in mouse lungs

Powerful treatment for IPF stops dangerous scar formation in mouse lungs

ASH publishes new guidelines to help tailor treatment for older adults with acute myeloid leukemia

ASH publishes new guidelines to help tailor treatment for older adults with acute myeloid leukemia

Study could refine treatment recommendations for younger adult patients with acute leukemia

Study could refine treatment recommendations for younger adult patients with acute leukemia

Researcher is exploring safer and more effective treatment for leukemia

Researcher is exploring safer and more effective treatment for leukemia

Study reveals impact of TP53 gene mutations on MDS severity

Study reveals impact of TP53 gene mutations on MDS severity

Long stretches of repeating DNA associated with susceptibility to systemic sclerosis

Long stretches of repeating DNA associated with susceptibility to systemic sclerosis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.